Page 27 - Bharat Biotech

Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline

ICMR launches a new vaccine portal for Covid, with details of trials

The portal covers other ailments as well; will provide details of progress made locally and globally at regular intervals

Bharat Biotech aims at billion Covaxin doses a year, phase-3 trials in Oct

Firm also ties up with Washington University's school of medicine for intransal vaccine for Covid-19

Bharat Biotech inks deal with Washington varsity for intranasal Covid vax

Bharat Biotech on Wednesday announced a licensing agreement with Washington University School of Medicine in St. Louis for a novel chimp-adenovirus, single dose intranasal vaccine for Covid-19

Govt in talks with Russia for advancement of Covid-19 vaccine: Health Min

The Central Drugs Standard Control Organisation (CDSCO) has informed that it has received information about one Covid-19 vaccine developed and approved in Russia

India's Covid-19 tally nears 5 mn with one-fifth of total cases active

India took six months to reach the first million covid cases and it has gone from four to 4.9 million in 11 days

Bharat Biotech's Covaxin succeeds in challenge trials on Rhesus monkeys

The results showed protective efficacacy, increasing Sars-CoV-2 specific IgG and neutralising antibodies reducing the replication of the virus in the nasal cavity, throat and lung tissues of monkey

Telangana to get priority in Bharat Biotech's Covid-19 vaccine supply: KCR

Telangana CM K Chandrashekhar Rao said his government was ensuring that Telangana, as the home state, gets priority in supply of Covid-19 vaccine as and when it is manufactured by Bharat Biotech

PGI Rohtak to start phase-2 trial of Bharat Biotech's Covid-19 vaccine

Post Graduate Institute (PGI) Rohtak will start the phase-2 human clinical trial of Bharat Biotech's COVID-19 vaccine

Phase II clinical trials of Bharat Biotech's Covid-19 vaccine from Sept 7

These trials of the BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for four days after they receive the vaccine shots

When will India finally have access to coronavirus vaccine?

India commands 40 per cent of global capacity for vaccines which is estimated at 5.7 billion doses

Top headlines: Q1 earnings shrink, telcos await SC verdict on AGR and more

From auto firms planning new launches for festive season, Rajnath Singh banning import of defence items to telcos awaiting SC response of AGR dues, here are the top ness of the day

Don't want to launch Covid vaccine under pressure, says Bharat Biotech CMD

Asserts safety and quality are important and that his firm will develop a vaccine that's affordable for all

Want to volunteer for a coronavirus vaccine trial? Things you should know

With the studies entering human trial phase, a critical requirement is to select volunteers who are willing to participate

Hyderabad's NIMS begins human trials of coronavirus vaccine Covaxin

The healthy volunteers, who were administered the first dose of the vaccine in the morning, were stable.

Covid-19: AIIMS to start human clinical trial of Covaxin from Monday

Covaxin is being tested in 12 places, according to the Indian Council for Medical Research.

Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Indian pharma can produce Covid-19 vaccines for entire world: Bill Gates

India's challenge immense in coronavirus crisis immense because of its large population, says billionaire philanthropist

Why vaccines can't be launched overnight

Under normal circumstances, the development of new vaccines and treatments could take 10-20 years

Covid-19 vaccine: Over to clinical sites to set a deadline for Covaxin

Sites may end with varying timelines based on site initiation visit by Bharat Biotech